These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 28387980)

  • 21. Evolution in Our Understanding of Hepatitis B Virus Virology and Immunology.
    Bengsch B; Chang KM
    Clin Liver Dis; 2016 Nov; 20(4):629-644. PubMed ID: 27742004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection.
    Meng Z; Chen Y; Lu M
    Front Immunol; 2019; 10():3127. PubMed ID: 32117201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular virology of hepatitis B virus and targets for antiviral intervention.
    Glebe D; König A
    Intervirology; 2014; 57(3-4):134-40. PubMed ID: 25034480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic hepatitis B: Immunological profile and current therapeutic vaccines in clinical trials.
    Lobaina Y; Michel ML
    Vaccine; 2017 Apr; 35(18):2308-2314. PubMed ID: 28351734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies.
    Novotny LA; Evans JG; Su L; Guo H; Meissner EG
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34207487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activating the innate immune response to counter chronic hepatitis B virus infection.
    Lamb C; Arbuthnot P
    Expert Opin Biol Ther; 2016 Dec; 16(12):1517-1527. PubMed ID: 27603796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B virus: from diagnosis to treatment.
    Dény P; Zoulim F
    Pathol Biol (Paris); 2010 Aug; 58(4):245-53. PubMed ID: 20580167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B virus: new therapeutic perspectives.
    Lin CL; Yang HC; Kao JH
    Liver Int; 2016 Jan; 36 Suppl 1():85-92. PubMed ID: 26725903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.
    Manesis EK; Papatheodoridis GV; Tiniakos DG; Hadziyannis ES; Agelopoulou OP; Syminelaki T; Papaioannou C; Nastos T; Karayiannis P
    J Hepatol; 2011 Jul; 55(1):61-8. PubMed ID: 21145875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotherapeutic interventions in chronic hepatitis B virus infection: a review.
    Wang L; Zou ZQ; Liu CX; Liu XZ
    J Immunol Methods; 2014 May; 407():1-8. PubMed ID: 24747918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of chronic hepatitis B in children.
    Shah U; Kelly D; Chang MH; Fujisawa T; Heller S; González-Peralta RP; Jara P; Mieli-Vergani G; Mohan N; Murray KF
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48(4):399-404. PubMed ID: 19322053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
    Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
    Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of chronic hepatitis B.
    Loomba R; Liang TJ
    Antivir Ther; 2007; 12 Suppl 3():H33-41. PubMed ID: 18284181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meeting the Challenge of Eliminating Chronic Hepatitis B Infection.
    Revill PA; Penicaud C; Brechot C; Zoulim F
    Genes (Basel); 2019 Apr; 10(4):. PubMed ID: 30939846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunopathogenesis of HBV Infection.
    Wu J; Han M; Li J; Yang X; Yang D
    Adv Exp Med Biol; 2020; 1179():71-107. PubMed ID: 31741334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Future prevention and treatment of chronic hepatitis B infection.
    Seto WK; Fung J; Yuen MF; Lai CL
    J Clin Gastroenterol; 2012 Oct; 46(9):725-34. PubMed ID: 22914347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B virus therapy: What's the future holding for us?
    Manzoor S; Saalim M; Imran M; Resham S; Ashraf J
    World J Gastroenterol; 2015 Nov; 21(44):12558-75. PubMed ID: 26640332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune therapy including dendritic cell based therapy in chronic hepatitis B virus infection.
    Akbar SM; Horiike N; Onji M
    World J Gastroenterol; 2006 May; 12(18):2876-83. PubMed ID: 16718812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of immunomodulatory therapy (other than interferon) for the treatment of chronic hepatitis B virus infection.
    Lau GK
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E46-52. PubMed ID: 10921382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic hepatitis B virus infection.
    Zoulim F
    Antiviral Res; 2004 Oct; 64(1):1-15. PubMed ID: 15451174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.